https://www.selleckchem.com/products/azd1390.html
s cytomembranes, cell cycle, and adipocytokine signaling. We successfully developed a GS based on genome-wide network, which may represent a novel prognostic factor for GC. A combination of GS and TNM staging provides additional precision in stratifying patients with different OS prognoses, constituting a more comprehensive sub-typing system. This could potentially play an important role in future clinical practice. We successfully developed a GS based on genome-wide network, which may represent a novel prognostic factor for GC. A combi
Like
Comment
Share
